Nomura Research Institute,Ltd. <4307> shares remain firm as goodwill impairment at overseas units sparks buying on earnings recovery expectations

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Apr 24, 2026 10:11 am JST Catalyst

Nomura Research Institute,Ltd. <4307> shares remained firm. After the close of trading on the 23rd, the company announced that its operating profit for the fiscal year ending March 2026 is expected to come in at 58.0 billion yen (down 57.0% year-on-year), 92.0 billion yen below the previous forecast, and net profit at 15.0 billion yen (down 84.0% year-on-year), 89.0 billion yen below the initial plan. The downward revision is due to the recognition of goodwill impairment losses at overseas subsidiaries. While the stock opened lower, buyers stepped in on dips, anticipating earnings recovery effects from the impairment charges.

Following a review of business plans at group companies NRI Australia and Core BTS in North America, the company expects to record impairment losses on goodwill and other assets totaling 96.9 billion yen. The impairment at NRI Australia reflects deteriorating performance due to reduced orders in the consulting and managed services businesses. For Core BTS, the company factored in the struggles of its cloud consulting business. Meanwhile, revenue for the previous fiscal year appears to have reached 814.0 billion yen (up 6.4% year-on-year) versus the forecast of 810.0 billion yen. The company is scheduled to announce its earnings on the 24th.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.